Old Dogs Can Teach Cancer Researchers New Tricks
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The FDA issued 18 oncology-related approvals in Q2 2024 including two first-in-class drugs and a bispecific T-cell engager for...
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
Dan Theodorescu and Lars Dyrskjøt preview the AACR's upcoming conference on bladder cancer.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Researchers are exploring new options for kidney cancer treatments.
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.